Inventor · disambiguated record
Martin Fleck
Also filed as: FLECK MARTIN · FLECK MARTIN THOMAS
30 granted patents·9 pending applications·59 citations·filing 2011–2024
94Inventor score
Top patents by PatentIndex Score
39 records- 0193US11661427B2Tetrazole derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted May 30, 2023·3 cites·32 claims
- 0293US11578080B2ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2021·Granted Feb 14, 2023·2 cites·33 claims
- 0390US11884681B23H,4H,5H,6H,7H-pyrimido[4,5-b][1,4]oxazine-4,6-dione derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jan 30, 2024·1 cites·9 claims
- 0490US11136336B2ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2020·Granted Oct 5, 2021·2 cites·12 claims
- 0589US11858921B2Uracil derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jan 2, 2024·1 cites·9 claims
- 0689US11078182B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 3, 2021·4 cites·35 claims
- 0788US8623860B2Azetidine derivatives, pharmaceutical compositions and uses thereofFLECK MARTIN·Filed 2012·Granted Jan 7, 2014·17 cites·10 claims
- 0887US11891403B2Tetrazole derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Feb 6, 2024·1 cites·34 claims
- 0987US10392419B2Modified cyclic dinucleotide compoundsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Aug 27, 2019·5 cites·73 claims
- 1082US10537590B2Cyclic dinucleotide compoundsBOEHRINGER INGELHEIM INT·Filed 2017·Granted Jan 21, 2020·4 cites·55 claims
- 1180US8772305B2Substituted pyridinyl-pyrimidines and their use as medicamentsDAHMANN GEORG·Filed 2012·Granted Jul 8, 2014·7 cites·22 claims
- 1277US2024352032A1Tetrazole derivatives as trpa1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1376US8835472B2Compounds, pharmaceutical compositions and uses thereofROTH GERALD JUERGEN·Filed 2011·Granted Sep 16, 2014·4 cites·8 claims
- 1474US2025092019A1Tetrazole derivatives as trpa1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1574US2023295112A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1674US2024352033A1Tetrazole derivatives as trpa1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1772US9006450B2Compounds, pharmaceutical compositions and uses thereofROTH GERALD JUERGEN·Filed 2011·Granted Apr 14, 2015·3 cites·9 claims
- 1870US2022048885A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 1969US8877754B2Compounds, pharmaceutical compositions and uses thereofROTH GERALD JUERGEN·Filed 2011·Granted Nov 4, 2014·2 cites·10 claims
- 2067US9340510B2Tetrahydroisoquinoline derivatives, pharmaceutical compositions and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted May 17, 2016·1 cites·11 claims
- 2166US11884652B2Tetrazole derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Jan 30, 2024·0 cites·34 claims
- 2266US9169205B2Pyrrolidine derivatives, pharmaceutical compositions and uses thereofFLECK MARTIN·Filed 2013·Granted Oct 27, 2015·1 cites·14 claims
- 2366US8877741B2Pyrrolidine derivatives, pharmaceutical compositions and uses thereofFLECK MARTIN·Filed 2014·Granted Nov 4, 2014·1 cites·14 claims
- 2465US12180223B23H,4H-thieno[2,3-d]pyrimidin-4-one derivatives as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Dec 31, 2024·0 cites·9 claims
- 2565US11878981B2Substituted 1,2,4-oxadiazoles as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2022·Granted Jan 23, 2024·0 cites·13 claims
- 2662US12497401B2Substituted tetrazoles as TRPA1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Granted Dec 16, 2025·0 cites·7 claims
- 2762US10864201B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Dec 15, 2020·0 cites·55 claims
- 2860US2021059992A1Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 2959US2021107919A1Novel ThienopyrimidonesBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3053US12358910B2Heteroaromatic compounds as Vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Jul 15, 2025·0 cites·14 claims
- 3151US12240828B2Heteroaromatic compounds as vanin inhibitorsBOEHRINGER INGELHEIM INT·Filed 2019·Granted Mar 4, 2025·0 cites·11 claims
- 3245US2021009627A1Cyclic dinucleotide compounds containing 2-aza-hypoxanthine or 6h-pytazolo[1,5-d][1,2,4]trizain-7-one as string agonistsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 3345US2021024567A1Modified cyclic dinucleotide compoundsBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 3444US9278954B2Pyrrolidine derivatives, pharmaceutical compositions and uses thereofHEINE NIKLAS·Filed 2014·Granted Mar 8, 2016·0 cites·13 claims
- 3543US8962641B2Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereofFLECK MARTIN·Filed 2014·Granted Feb 24, 2015·0 cites·13 claims
- 3641US8765959B2Piperidine derivativesROTH GERALD JUERGEN·Filed 2012·Granted Jul 1, 2014·0 cites·16 claims
- 3741US8759528B2Piperidine derivatives, pharmaceutical compositions and uses thereofROTH GERALD JUERGEN·Filed 2012·Granted Jun 24, 2014·0 cites·11 claims
- 3841US8530460B2Azetidine derivativesFLECK MARTIN·Filed 2012·Granted Sep 10, 2013·0 cites·11 claims
- 3938US8530461B2Azetidine derivativesNOSSE BERND·Filed 2012·Granted Sep 10, 2013·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Martin Fleck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →